Skip to main content

Biotechnology Industry Organization (BIO) Provides Supplemental Comments on PTO s.101 Guidelines

Biotechnology Industry Organization (BIO) Provides Supplemental Comments on PTO s.101 Guidelines
Tuesday, October 21, 2014

BIO recently generated a letter to the PTO on the March 6th Guidelines on the patent-eligibility of subject matter in the life sciences, particularly “natural products.” BIO invited a group of in-house and private practitioners to comment on the Guidelines and a number of them – including myself – signed off on the letter. Following appearances by a Mr. Hirschfeld at a number of industry conferences and symposia, the biotech/pharma community felt that there is a realistic chance the initial Guidelines will be released in revised form in the near future.

Supplemental comments on USPTO Myriad guidance (10-14).

© 2024 Schwegman, Lundberg & Woessner, P.A. All Rights Reserved.